CCL28 and rheumatoid arthritis: Neutralization of CCL28 in RA synovial fluid (SF) or blockade of CCR10 on human endothelial progenitor cells (EPCs) significantly reduced SF-induced endothelial migration and capillary formation indicating that CCL28/CCR10 is involved in pathological RA angiogenesis (Chen et al., 2015).